Wolverine Trading
BLUE

Wolverine Trading’s bluebird bio BLUE Stock Holding History

Wolverine Trading’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,500
Closed -$381K – 4772
2024
Q4 		$381K Buy
48,500
+47,075
+3,304% +$411K ﹤0.01% 3738
2024
Q3 		$14.4K Buy
1,425
+95
+7% +$1.58K ﹤0.01% 4662
2024
Q2 		$26.2K Sell
1,330
-1,375
-51% -$27.5K ﹤0.01% 4303
2024
Q1 		$69.2K Sell
2,705
-1,295
-32% -$33.2K ﹤0.01% 4144
2023
Q4 		$110K Buy
4,000
+2,445
+157% +$149K ﹤0.01% 4081
2023
Q3 		$94.5K Buy
1,555
+285
+22% +$20K ﹤0.01% 4012
2023
Q2 		$81.8K Sell
1,270
-15
-1% -$1.1K ﹤0.01% 3831
2023
Q1 		$81K Sell
1,285
-560
-30% -$64K ﹤0.01% 3710
2022
Q4 		$255K Sell
1,845
-825
-31% -$116K ﹤0.01% 2923
2022
Q3 		$304K Buy
+2,670
New +$302K ﹤0.01% 3139
2021
Q4 		– Sell
-1,220
Closed -$300K – 5904
2021
Q3 		$300K Sell
1,220
-1,057
-46% -$302K ﹤0.01% 4702
2021
Q2 		$887K Buy
2,277
+393
+21% +$156K ﹤0.01% 2925
2021
Q1 		$698K Sell
1,884
-918
-33% -$452K ﹤0.01% 3235
2020
Q4 		$1.6M Buy
2,802
+911
+48% +$577K ﹤0.01% 1915
2020
Q3 		$1.35M Buy
1,891
+139
+8% +$108K ﹤0.01% 1791
2020
Q2 		$1.36M Sell
1,752
-109
-6% -$82.2K ﹤0.01% 1720
2020
Q1 		$1.13M Sell
1,861
-1,729
-48% -$1.68M ﹤0.01% 1802
2019
Q4 		$4.07M Buy
3,590
+911
+34% +$990K 0.01% 1260
2019
Q3 		$3.22M Buy
2,679
+8
+0.3% +$12.2K 0.01% 1116
2019
Q2 		$4.4M Buy
+2,671
New +$4.62M 0.01% 977
2018
Q4 		– Sell
-4,794
Closed -$9.07M – 4437
2018
Q3 		$9.07M Buy
4,794
+1,606
+50% +$3.32M 0.02% 608
2018
Q2 		$7.05M Hold
3,188
– – 0.02% 668
2018
Q1 		$7.05M Buy
3,188
+54
+2% +$137K 0.02% 668
2017
Q4 		$7.23M Buy
3,134
+278
+10% +$564K 0.03% 651
2017
Q3 		$5.08M Buy
+2,856
New +$3.99M 0.02% 756
2017
Q2 		– Sell
-757
Closed -$899K – 4272
2017
Q1 		$899K Buy
757
+232
+44% +$237K 0.01% 1810
2016
Q4 		$420K Buy
+525
New +$417K ﹤0.01% 2836

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Wolverine Trading's BLUE Position: Q4 2024 in Review

Wolverine Trading sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 895 shares — an estimated $7.82K sold.

Wolverine Trading first reported a position in BLUE in Q3 2017 and held it in 22 quarters. The position peaked at $4.51M in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Wolverine Trading reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 895 bluebird bio shares in Q4 2024, an estimated $7.82K.
  • Wolverine Trading first reported a position in bluebird bio in Q3 2017 and held it in 22 quarters.
  • Wolverine Trading's bluebird bio position peaked at $4.51M in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.